Related Experiment Video

Updated: Aug 19, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 14, 2010

Borderline tuberculoid Hansen's disease in AIDS

D R Goodless1, A L Viciana, R J Pardo

  • 1Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, FL 33101.

Journal of the American Academy of Dermatology
|May 1, 1994
PubMed

Insights

Human immunodeficiency virus (HIV) infection does not significantly alter the immune response to Mycobacterium leprae (Hansen's disease) in patients with AIDS. The skin lesions showed typical characteristics, indicating the immune system still fights leprosy effectively.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Dermatology

Background:

  • Investigating the impact of Human Immunodeficiency Virus (HIV) infection on the immune response to Mycobacterium leprae (Hansen's disease).
  • Examining a patient with Acquired Immunodeficiency Syndrome (AIDS) and borderline tuberculoid Hansen's disease.

Observation:

  • Immunohistochemical analysis of skin lesions was performed.
  • Peripheral blood flow cytometric analysis was conducted.
  • Laboratory features associated with immunosuppression were evaluated.

Findings:

  • The in situ immunologic response to Mycobacterium leprae was minimally affected by HIV infection and immunosuppression.
  • Skin lesions exhibited characteristics typical of borderline tuberculoid Hansen's disease.
  • Despite laboratory evidence of immunosuppression in AIDS, the immune response to M. leprae remained largely unchanged.

Implications:

  • HIV infection does not substantially impair the host's immune response to Mycobacterium leprae.
  • This suggests that Hansen's disease management in HIV-positive individuals may follow standard protocols.
  • Further research into immune reconstitution and leprosy in co-infected patients is warranted.

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...